Th17/Treg imbalance and increased interleukin-21 are associated with liver injury in patients with chronic severe hepatitis B
- 1 May 2017
- journal article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 46, 48-55
- https://doi.org/10.1016/j.intimp.2017.02.019
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (30972584, 30930082, 81171561)
- National Science and Technology Major Project of China (2008ZX10002-006, 2012ZX10002007001)
This publication has 37 references indexed in Scilit:
- The role of innate immunity in the immunopathology and treatment of HBV infectionJournal of Hepatology, 2016
- Adaptive immunity in HBV infectionJournal of Hepatology, 2016
- Early warning and clinical outcome prediction of acute-on-chronic hepatitis B liver failureWorld Journal of Gastroenterology, 2015
- Ratios of regulatory T cells/T‐helper 17 cells and transforming growth factor‐β1/interleukin‐17 to be associated with the development of hepatitis B virus‐associated liver cirrhosisJournal of Gastroenterology and Hepatology, 2013
- Involvement of Th17 and Th1 Effector Responses in Patients with Hepatitis BJournal of Clinical Immunology, 2010
- Hepatitis B virus infectionThe Lancet, 2009
- Natural history of chronic hepatitis B virus infection and long‐term outcome under treatmentLiver International, 2009
- A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responsesNature Immunology, 2008
- Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathwayBlood, 2008
- A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17Nature Immunology, 2005